• Users Online: 340
  • Print this page
  • Email this page
Year : 2022  |  Volume : 18  |  Issue : 4  |  Page : 139-140

Escitalopram-induced hyperprolactinemic galactorrhea

Department Obstetrics and Gynecology, All India Institute of Medical Sciences (AIIMS), Mangalagiri, Andhra Pradesh, India

Correspondence Address:
Dr. Vijayan Sharmila
Department of Obstetrics and Gynecology, All India Institute of Medical Sciences (AIIMS), Mangalagiri 522 503, Andhra Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AMJM.AMJM_50_22

Rights and Permissions

Galactorrhea is milky secretions from the breast in women who have not breast-fed for a year. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), owing to its potency and tolerance, is regarded as the primary line drug in the management of depression and anxiety disorders. SSRIs may rarely cause symptoms brought on by enhanced prolactin levels. Antidepressants that increase serotonin may additionally cause a rise in prolactin by improving dopamine neurotransmission. In the current research, we present a case of hyperprolactinemic galactorrhea linked to escitalopram. A 32-year-old woman presented with bilateral breast heaviness and milky secretions after using escitalopram for anxiety and her serum prolactin level was found to be elevated. Galactorrhea disappeared and her prolactin level returned to normal after escitalopram was stopped.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal